NCT00038883View on ClinicalTrials.gov

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

NATerminatedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

April 9, 2001

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Leukemia, Lymphocytic, ChronicLeukemia, Lymphocytic, AcuteLymphoma, Low-GradeLymphoma, T-CellLymphoma, B-Cell

Interventions

DRUG

Campath-1H

10 mg/day x 5, starting with the first day of chemotherapy

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Leudosite

UNKNOWN

lead

M.D. Anderson Cancer Center

OTHER